Therapeutic support protocol for patient with dysosmia with or without dysgeusia related to the SARS-CoV2 virus infection

Main Article Content

Ignazio Milone
Riccardo Vento
Luigi Ippolito
Samuel Paroni
Maurizio Giuseppe Vento


dysosmia, dysgeusia, Hyposmia, anosmia, covid-19, therapy, coronavirus, ORL, otolaryngology




Download data is not yet available.


Metrics Loading ...
Abstract 211 | PDF Downloads 77


1. Jerome R. Lechien, Carlos M. Chiesa-Estomba, Daniele R. De Siati, et all.; Olfactory and gustatory dysfunction as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter european study; Eur Arch Otorhinolaryngol. 2020 Apr 6:1-11.
2. Klopfenstein T., Kadiane-Oussou N.J., Toko L., et all.; Features of anosmia in COVID-19; Med Mal Infect. 2020 Apr 17:S0399-077X(20)30110-4
3. Yan C.H., Faraji F., Prajapati D.P., et all.; Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms; Int Forum Allergy Rhinol. 2020 Apr 12:10.1002/alr.22579.
4. Voutilainen A., Pitkäaho T., Kvist T., et all.; How to ask about patient satisfaction? The visual analogue scale is less vulnerable to confounding factors and ceiling effect than a symmetric Likert scale; J Adv Nurs. 2016 Apr;72(4):946-57.